Would the proposed joint regulatory scheme be subject to judicial review?
Yes. Existing Australian and New Zealand judicial review processes will be adapted to accommodate the proposed joint regulatory scheme. For the purposes of the joint regulatory scheme, decisions made by the High Court of New Zealand or the Federal Court of Australia would be effective in both countries. Will Australian and New Zealand consumers and industry be able to influence the operation of the Authority? Yes. Australian and New Zealand consumers, industry and other stakeholders will be able to provide input into aspects of the Authority’s operation because the Authority will be accountable to the Australian Minister for Health and Ageing, the New Zealand Minister of Health and to the Australian and New Zealand Parliaments; companies and consumers would be able to raise any issues with their Minister or with their Member of Parliament. Is the model for the ANZTPA different from the trans-Tasman food standards model? Yes. The model for the therapeutic products Authority is different
Related Questions
- How does the proposed Judicial Review proceedings challenging the Government’s response to the Parliamentary Ombudsman’s report on Equitable Life impact on Sir John’s Work?
- Is the proposed merger subject to approvals from shareholders and/ or other authorities or regulatory bodies?
- Would the proposed joint regulatory scheme be subject to judicial review?
